Cary J Claiborne
CIK 1370930 · Chief Executive Officer · last filed 2026-04-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SCMP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ELLICOTT CITY, MD 21042
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADIL | Chief Executive Officer | 40,417 | $3.89 | $157.2K | $0 | 4 | 2026-04-09 |
| ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Chief Executive Officer | 1,520,000 | $0.00 | $1.4K | $0 | 6 | 2023-05-25 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Chief Financial Officer | 45,764 | — | — | -$734.6K | 18 | 2014-12-17 |
| New Generation Biofuels Holdings, Inc (NGBF) Delisted | CEO, CFO and President | 283,179 | — | — | $28.2K | 9 | 2009-12-29 |
| New Generation Biofuels Holdings, Inc (GNB) Delisted | Chief Financial Officer | 10,236 | — | — | $0 | 1 | 2008-06-06 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Chief Financial Officer | 75,000 | — | — | $0 | 3 | 2007-11-23 |
Recent Filings · Page 4 of 5
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-12-22 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Buy (P) | +20,000 | $14.0K | EDGAR |
| 2009-12-21 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Grant (A) | +29,070 | $0 | EDGAR |
| 2009-08-28 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Mixed | +30,672 | $0 | EDGAR |
| 2009-07-01 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Grant (A) | +29,531 | $0 | EDGAR |
| 2009-07-01 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Grant (A) | +120,470 | $0 | EDGAR |
| 2009-06-11 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Grant (A) | +29,531 | $0 | EDGAR |
| 2009-05-29 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-16 | New Generation Biofuels Holdings, Inc (NGBF) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2008-06-06 | New Generation Biofuels Holdings, Inc (GNB) Delisted | Mixed | +2,986 | $0 | EDGAR |
| 2008-01-11 | — | Grant (A) | +6,250 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.